Mallinckrodt $750 million 5.625% bond issue

9/9/2015

Investment grade bond/note issue

Value:

$ 750 million

Status:

Completed

Date:

9/9/2015

Overview:

Mallinckrodt has issued $750 million of senior unsecured notes.
The 5.625% notes are due 2023 and issued under Rule144A/Reg S.
Mallinckrodt is a biopharmaceutical and medical imaging business.
Barclays, Citigroup, Deutsche Bank, Goldman Sachs and Wells Fargo acted as bookrunners.
The proceeds of the business will be used to finance the acquisition of TGG medical Solutions.

Sam Duke - Editor

Jurisdiction:

Ireland

Deal type:

Investment grade bond/note issue

Practice area:

Capital markets : Debt

Industry sector:

Pharmaceuticals and life sciences

Firms:

A&L Goodbody

Party: Barclays (Bookrunner)

Lawyer: Peter Murray

Arthur Cox

Party: Mallinckrodt (Issuer)

Related deals